CINGULATE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7172 USD | +2.46% |
|
-13.07% | -90.62% |
| 05-21 | FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD | CI |
| 05-08 | Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.8700 | 3.360 | 3.652 |
| Spread/Res. | -17.56% | -78.65% | -80.36% |
| Spread/Supp. | +2.46% | +2.46% | +238.30% |
| Support | 0.7000 | 0.7000 | 0.2120 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- CING Stock
- Charts Cingulate Inc.
